Recital 5, Regulation (EU) 2026/314

In forcesince 9 Feb 2026

The Commission mandated the European Drugs Agency (EUDA) to assess the nine substances and provide information both on licit and illicit uses [EUDA home page | www.euda.europa.eu.]. According to the EUDA, the nine substances may be used in the illicit production of drugs through straightforward and scalable methods, needing only basic equipment and minimal technical proficiency to be executed. The seizures of those precursors increased in recent years in the Union. Some of them are used in the production of medicines marketed in the EU: 3'-chloropropiophenone is used in production of bupropion, a medicine intended for the treatment of depression and as an aid to smoking cessation. 2-Bromo-3'-chloropropiophenone is an intermediate in the manufacture of bupropion. 4'-Methylpropiophenone is used in production of tolperisone, a muscle-relaxant authorised for the treatment of muscle spasms and spasticity caused by different conditions. Phenyl-2-nitropropene may be used in the production of amphetamine-based medicines. In addition, the EUDA confirms that all nine substances concerned have legitimate uses as reference standards in analytical laboratories.